INTEGRA Supports Breast Cancer Research

INTEGRA Biosciences has launched PIPETGIRL - a new pink version of its popular PIPETBOY acu 2 pipette controller.

As part of their 'PIPETGIRL – Let’s fight breast cancer together!’ campaign - INTEGRA is committing to donating Euro 10 / US $15 for every PIPETGIRL purchased during 2015 to a selection of internationally renowned cancer research institutes.

Liquid handling in the millilitre range is a daily task for many labs. Unlike rubber bulb fillers, the use of serological pipettors improves the efficiency and precision of your liquid handling. The PIPETGIRL pipette controller combines all the essential characteristics for productive work with serological pipettes - precision, speed, ease of use, lightweight operating comfort, long battery life and reliability. The PIPETGIRL Is designed for use with all commercially available glass and plastic serological pipettes in the volume range 1 - 100 ml. Each PIPETGIRL pipette controller comes with a 3-year extended warranty to safeguard your investment.

Pipetting using PIPETGIRL is controlled by two operating buttons and an adjustment wheel for setting the pipetting speed. Precision pipetting is easily achieved by applying a slight pressure on the operating button. A special turbo mode makes the PIPETGIRL the fastest pipettor on the market.

To register your interest in supporting the global fight against Breast cancer and to learn more about the PIPETGIRL pipette controller please visit http://www.integra-biosciences.com/sites/pipetgirl.html or contact INTEGRA Biosciences in North / South America on telephone +1-603-578-5800 / email [email protected] or in Europe / Asia on telephone +41-81-286-9530 / email [email protected]

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2015, February 10). INTEGRA Supports Breast Cancer Research. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20150210/INTEGRA-Supports-Breast-Cancer-Research.aspx.

  • MLA

    INTEGRA Biosciences. "INTEGRA Supports Breast Cancer Research". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20150210/INTEGRA-Supports-Breast-Cancer-Research.aspx>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA Supports Breast Cancer Research". News-Medical. https://www.news-medical.net/news/20150210/INTEGRA-Supports-Breast-Cancer-Research.aspx. (accessed November 21, 2024).

  • Harvard

    INTEGRA Biosciences. 2015. INTEGRA Supports Breast Cancer Research. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20150210/INTEGRA-Supports-Breast-Cancer-Research.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
INTEGRA Biosciences’ pipettes pave the way for epigenetics testing